QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve outpatient respiratory treatment
QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions